Video Experimental Relacionado
Updated: Jan 23, 2026

Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Navegando la Terapia de la Anemia en la ERC: El Rol de los Activadores del Factor Inducible por Hipoxia
Volker H Haase1, Nadiesda A Costa2, Mark J Koury3
1Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center and Vanderbilt University School of Medicine, Nashville, TN, 37232; Medical Service, Dept. of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, 37212; Research Service, Dept. of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, 37212.
Nuevos fármacos orales para la anemia, los inhibidores de la prolilhidroxilasa del factor inducible por hipoxia (HIF-PHI), controlan eficazmente la hemoglobina en la enfermedad renal crónica (ERC). Ofrecen una alternativa a los agentes estimulantes de la eritropoyesis (ESA), pero requieren una mayor evaluación de seguridad en pacientes con ERC no dializados.
Videos de Conceptos Relacionados
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Activity Coefficient
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
Hypoxia
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Transcription Factors
Gene Therapy
Transcription Elongation Factors
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...

